BSX

BSX

USD

Boston Scientific Corporation Common Stock

$98.840-0.140 (-0.141%)

Reaalajas hind

Healthcare
Meditsiiniseadmed
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$98.980

Kõrge

$99.310

Madal

$98.250

Maht

4.81M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

146.5B

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

8.69M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $84.13Praegune $98.840Kõrge $109.5

Seotud uudised

Analyst Upgrades

Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130

Truist Securities analyst Richard Newitter maintains Boston Scientific with a Buy and raises the price target from $129 to $130.

Vaata rohkem
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific with a Overweight and raises the price target from $124 to $125.

Vaata rohkem
Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125
Analyst Upgrades

Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130

Morgan Stanley analyst Patrick Wood maintains Boston Scientific with a Overweight and raises the price target from $125 to $130.

Vaata rohkem
Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target

BTIG analyst Marie Thibault reiterates Boston Scientific with a Buy and maintains $132 price target.

Vaata rohkem
BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target
Analyst Upgrades

Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance.

Vaata rohkem
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
PR Newswire

Boston Scientific announces results for third quarter 2025

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $110

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific with a Outperform and lowers the price target from $115 to $110.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.